Treatment Patterns, Drug Survival, and Effectiveness of Tildrakizumab Among Patients with Prior Interleukin-17 Experience in the PPD CorEvitas Psoriasis Registry

Dermatology and Therapy · Published 2026-07-30 · DOI 10.1007/s13555-026-01842-7

Free full text

Authors (7)

Mark G. Lebwohl, Ranga Gogineni, Asif Shaikh, Taylor Blachley, Thomas Eckmann, Alicia Beeghly, Jerry Bagel

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Lebwohl, M., Gogineni, R., Shaikh, A., et al. (2026). Treatment Patterns, Drug Survival, and Effectiveness of Tildrakizumab Among Patients with Prior Interleukin-17 Experience in the PPD CorEvitas Psoriasis Registry. Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01842-7

Related articles